|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global Cancer Statistics 2011. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
3.
|
Rogers SN, Brown JS, Woolgar JA, et al:
Survival following primary surgery for oral cancer. Oral Oncol.
45:201–211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Brandwein-Gensler M, Teixeira MS, Lewis
CM, et al: Oral squamous cell carcinoma. Histologic risk
assessment, but not margin status, is strongly predictive of local
disease-free and overall survival. Am J Surg Pathol. 29:167–178.
2005.
|
|
5.
|
Kernohan MD, Clark JR, Gao K, Ebrahimi A
and Milross CG: Predicting the prognosis of oral squamous cell
carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg.
136:1235–1239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yanamoto S, Yamada S, Takahashi H, et al:
Clinicopathological risk factors for local recurrence in oral
squamous cell carcinoma. Int J Oral Maxillofac Surg. 41:1195–1200.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Liao CT, Chang JTC, Wang HM, et al:
Analysis of risk factors of predictive local tumor control in oral
cavity cancer. Ann Surg Oncol. 15:915–922. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ord RA, Kolokythas A and Reynolds MA:
Surgical salvage for local and regional recurrence in oral cancer.
J Oral Maxillofac Surg. 64:1409–1414. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Braakhuis BJM, Bloemena E, Leemans CR and
Brakenhoff RH: Molecular analysis of surgical margins in head and
neck cancer: more than a marginal issue. Oral Oncol. 46:485–491.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Partridge M, Li SR, Pateromichelakis S, et
al: Detection of minimal residual cancer to investigate why oral
tumors recur despiteseemingly adequate treatment. Clin Cancer Res.
6:2718–2725. 2000.PubMed/NCBI
|
|
11.
|
van Houten VMM, Leemans CR, Kummer JA, et
al: Molecular diagnosis of surgical margins and local recurrence in
head and neck cancer patients: a prospective study. Clin Cancer
Res. 10:3614–3620. 2004.PubMed/NCBI
|
|
12.
|
Bilde A, von Buchwald C, Dabelsteen E,
Therkildsen MH and Dabelsteen S: Molecular markers in the surgical
margin of oral carcinomas. J Oral Pathol Med. 38:72–78. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yanamoto S, Yamada S, Takahashi H, et al:
Predictors of locoregional recurrence in T1-2N0 tongue cancer
patients. Pathol Oncol Res. 19:795–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kim JJ and Tannock IF: Repopulation of
cancer cells during therapy: an important cause of treatment
failure. Nat Rev Cancer. 5:516–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yoshikawa M, Tsuchihashi K, Ishimoto T, et
al: xCT-expressing tumor cells that are resistant to EGFR-targeted
therapy in head and neck squamous cell carcinoma. Cancer Res.
73:1855–1866. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Naor D, Sionov RV and Ish-Shalom D: CD44:
structure, function, and association with the malignant process.
Adv Cancer Res. 71:241–319. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Nagano O, Okazaki S and Saya H: Redox
regulation in stem-like cancer cells by CD44 variant isoforms.
Oncogene. 32:5191–5198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Jijiwa M, Demir H, Gupta S, et al: CD44v6
regulates growth of brain tumor stem cells partially through the
AKT-mediated pathway. PLoS One. 6:e242172011. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lee HJ, Eom DW, Kang GH, et al: Colorectal
micropapillary carcinomas are associated with poor prognosis and
enriched in markers of stem cells. Mod Pathol. 26:1123–1131. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Gaviraghi M, Tunici P, Valensin S, et al:
Pancreatic cancer spheres are more than just aggregates of stem
marker-positive cells. Biosci Rep. 31:45–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Mack B and Gires O: CD44s and CD44v6
expression in head and neck epithelia. PLoS One. 3:e33602008.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Zhou S, Schuetz JD, Bunting KD, et al: The
ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem
cells and is a molecular determinant of the side-population
phenotype. Nat Med. 67:1028–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Zhang P, Zhang Y, Mao L, Zhang Z and Chen
W: Side population in oral squamous cell carcinoma possesses tumor
stem cell phenotypes. Cancer Lett. 277:227–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Yanamoto S, Kawasaki G, Yamada S, et al:
Isolation and characterization of cancer stem-like side population
cells in human oral cancer cells. Oral Oncol. 47:855–860. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Bryne M, Koppang HS, Lilleng R and
Kjaerheim A: Malignancy grading of the deep invasive margins of
oral squamous cell carcinoma has high prognostic value. J Pathol.
166:375–381. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Asakage T, Yokose T, Mukai K, et al: Tumor
thickness predicts cervical metastasis in patients with stage I/II
carcinoma of the tongue. Cancer. 82:1443–1448. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Kurokawa H, Yamashita Y, Takeda S, Zhang
M, Fukuyama H and Takahashi T: Risk factors for late cervical lymph
node metastases in patients with stage I or II carcinoma of the
tongue. Head Neck. 24:731–736. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Lim SC, Zhang S, Ishii G, et al:
Predictive markers for late cervical metastasis in stage I and II
invasive squamous cell carcinoma of the oral tongue. Clin Cancer
Res. 10:166–172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Sparano A, Weinstein G, Chalian A, Yodul M
and Weber R: Multivariate predictors of occult neck metastasis in
early oral tongue cancer. Otolaryngol Head Neck Surg. 131:472–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Huang SH, Hwang D, Lockwood G, Goldstein
DP and O’Sullivan B: Predictive value of tumor thickness for
cervical lymph-node involvement in squamous cell carcinoma of the
oral cavity. A meta-analysis of reported studies Cancer.
115:1489–1497. 2009.PubMed/NCBI
|
|
31.
|
Fan KH, Wang HM, Kang CJ, et al: Treatment
results of postoperative radiotherapy on squamous cell carcinoma of
the oral cavity: coexistence of multiple minor risk factors results
in higher recurrence rates. Int J Radiat Oncol Biol Phys.
77:1024–1029. 2010. View Article : Google Scholar
|
|
32.
|
Schneider PM, Baldus SE, Metzger R, et al:
Histomorphologic tumor regression and lymph node metastases
determine prognosis following neoadjuvant radiochemotherapy for
esophageal cancer. Ann Surg. 242:684–692. 2005. View Article : Google Scholar
|
|
33.
|
Bollschweiler E, Besch S, Drebber U, et
al: Influence of neoadjuvant chemoradiation on the number and size
of analyzed lymph nodes in esophageal cancer. Ann Surg Oncol.
17:3187–3194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Ota S, Ishii G, Goto K, et al:
Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen
predicts survival in advanced non-small-cell lung cancer treated
with cisplatin-based chemotherapy. Lung Cancer. 64:98–104. 2009.
View Article : Google Scholar
|
|
35.
|
Hang D, Dong HC, Ning T, Dong B, Hou DL
and Xu WG: Prognostic value of the stem cell markers CD133 and
ABCG2 expression in esophageal squamous cell carcinoma. Dis
Esophagus. 25:638–644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Zhao H, Ren J, Zhuo X, Ye H, Zou J and Liu
S: Prognostic significance of surviving and CD44v6 in laryngeal
cancer surgical margins. J Cancer Res Clin Oncol. 134:1051–1058.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Graziano A, d’Aquino R, Tirino V,
Desiderio V, Rossi A and Pirozzi G: The stem cell hypothesis in
head and neck cancer. J Cell Biochem. 103:408–412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Prince ME and Ailles LE: Cancer stem cells
in head and neck squamous cell cancer. J Clin Oncol. 26:2871–2875.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Sinha N, Mukhopadhyay S, Das DN, Panda PK
and Bhutia SK: Relevance of cancer initiating/stem cells in
carcinogenesis and therapy resistance in oral cancer. Oral Oncol.
49:854–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Screaton GR, Bell MV, Jackson DG, Cornelis
FB, Gerth U and Bell JI: Genomic structure of DNA encoding the
lymphocyte homing receptor CD44 reveals at least 12 alternatively
spliced exons. Proc Natl Acad Sci USA. 89:12160–12164. 1992.
View Article : Google Scholar
|
|
43.
|
Goodison S, Urquidi V and Tarin D: CD44
cell adhesion molecules. Mol Pathol. 52:189–196. 1999. View Article : Google Scholar
|
|
44.
|
Wang SJ, Wong G, de Heer AM, Xia W and
Bourguignon LY: CD44 variant isoforms in head and neck squamous
cell carcinoma progression. Laryngoscope. 119:1518–1530. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Yang YM and Chang JW: Bladder cancer
initiating cells (BCICs) are among (initiating) cells. Cancer
Invest. 26:725–733. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Shi J, Zhou Z, Di W and Li N: Correlation
of CD44v6 expression with ovarian cancer progression and
recurrence. BMC Cancer. 13:1822013. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Shen B, Dong P, Li D and Gao S: Expression
and function of ABCG2 in head and neck squamous cell carcinoma and
cell lines. Exp Ther Med. 2:1151–1157. 2011.PubMed/NCBI
|
|
48.
|
Lore JM, Diaz-Ordaz E, Spaulding M, et al:
Improved survival with preoperative chemotherapy followed by tumor
response for advanced squamous cell carcinoma of the head and neck.
Am J Surg. 170:506–511. 1995. View Article : Google Scholar
|
|
49.
|
Pignon JP, Bourhis J, Domenge C and
Designe L: Chemotherapy added to locoregional treatment for head
and neck squamous cell carcinoma: three meta-analyses of updated
individual data. Lancet. 355:949–955. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Licitra L, Grandi C, Guzzo M, et al:
Primary chemotherapy in resectable oral cavity squamous cell
carcinoma: a randomized controlled trial. J Clin Oncol. 21:327–333.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Olasz L, Szalma J, Orsi E, Tornoczky T,
Marko T and Nyarady Z: Neoadjuvant chemotherapy: does it have
benefits for surgeon in the treatment of advanced squamous cell
cancer of the oral cavity? Pathol Oncol Res. 16:207–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Costa S, Terzano P, Bovicelli A, et al:
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response
to neoadjuvant chemo-therapy in cervical carcinoma. Gynecol Oncol.
80:67–73. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Saigusa S, Tanaka K, Toiyama Y, et al:
Clinical significance of CD133 and hypoxia inducible factor-1α gene
expression in rectal cancer after preoperative chemotherapy. Clin
Oncol. 23:323–332. 2011.PubMed/NCBI
|
|
54.
|
Kawamoto A, Tanaka K, Saigusa S, et al:
Clinical significance of radiation-induced CD133 expression in
residual rectal cancer cells after chemoradiotherapy. Exp Ther Med.
3:403–409. 2012.
|
|
55.
|
Sprenger T, Conradi L, Beissbarth T, et
al: Enrichment of CD133-expressing cells in rectal cancers treated
with preoperative radiochemotherapy is an independent marker for
metastasis and survival. Cancer. 119:26–35. 2013. View Article : Google Scholar
|
